Skip to main content
Top
Published in: BMC Public Health 1/2018

Open Access 01-12-2018 | Research article

Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?

Authors: Joanne M. Osborne, Carlene Wilson, Amy Duncan, Stephen R. Cole, Ingrid Flight, Deborah Turnbull, Donna L. Hughes, Graeme P. Young

Published in: BMC Public Health | Issue 1/2018

Login to get access

Abstract

Background

Participation at the recommended intervals is critical for screening to be effective in reducing colorectal cancer (CRC) incidence. This study describes patterns of screening participation over four rounds of fecal immunochemical testing (FIT) to identify whether demographic variables and prior screening satisfaction are significantly associated with patterns of re-participation.

Methods

Baseline surveys were mailed to 4000 South Australians randomly selected from the electoral-roll. Respondents (n = 1928/48.2%) were offered four annual FIT rounds. Screening participation and satisfaction at each round were recorded.

Results

Study participation was 58.5, 66.9, 73.1 and 71.4% respectively over four rounds. Three participation patterns were described: consistent participation (43.1%), consistent non-participation (26.4%) and inconsistent participation (changeable; 30.5%), including intermittent and sustained change patterns. Sustained change described those who changed participatory behavior and then maintained for at least two rounds (n = 375/19.5%). Older people, and those not working were most likely to sustain participation. Younger invitees, especially men, were more likely to change participatory behavior and sustain the change. People with higher disadvantage, less education, not working and with no prior (pre-trial) screening experience were more likely to start participating and drop out. People dissatisfied with a prior screening test, including finding aspects embarrassing or unpleasant, were also more likely not to participate in annual screening or to drop out.

Conclusions

The findings identify those at risk of non- or inconsistent participation in rescreening. They should aid targeting of interventions for demographic groups at risk and ensuring screening experiences are not perceived as unpleasant or difficult.
Literature
1.
go back to reference Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343(22):1603–7.CrossRefPubMed Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343(22):1603–7.CrossRefPubMed
2.
go back to reference Ventura L, Mantellini P, Grazzini G, Castiglione G, Buzzoni C, Rubeca T, et al. The impact of immunochemical faecal occult blood testing on colorectal cancer incidence. Dig Liver Dis. 2014;46(1):82–6.CrossRefPubMed Ventura L, Mantellini P, Grazzini G, Castiglione G, Buzzoni C, Rubeca T, et al. The impact of immunochemical faecal occult blood testing on colorectal cancer incidence. Dig Liver Dis. 2014;46(1):82–6.CrossRefPubMed
3.
go back to reference Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103(6):1541–9.CrossRefPubMed Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103(6):1541–9.CrossRefPubMed
4.
go back to reference Australian Cancer Network Colorectal Cancer Guidelines Revision Committee. Guidelines for the prevention, early detection and management of colorectal cancer. Sydney: The Cancer Council Australia and Australian Cancer Network; 2005. Australian Cancer Network Colorectal Cancer Guidelines Revision Committee. Guidelines for the prevention, early detection and management of colorectal cancer. Sydney: The Cancer Council Australia and Australian Cancer Network; 2005.
6.
go back to reference Denis B, Gendre I, Perrin P. Participation in four rounds of a French colorectal cancer screening programme with guaiac faecal occult blood test: a population-based open cohort study. J Med Screen. 2015;22:76–82. Denis B, Gendre I, Perrin P. Participation in four rounds of a French colorectal cancer screening programme with guaiac faecal occult blood test: a population-based open cohort study. J Med Screen. 2015;22:76–82.
7.
go back to reference Janda M, Hughes KL, Auster JF, Leggett BA, Newman BM. Repeat participation in colorectal cancer screening utilizing fecal occult blood testing: a community-based project in a rural setting. J Gastroenterol Hepatol. 2010;25(10):1661–7.CrossRefPubMed Janda M, Hughes KL, Auster JF, Leggett BA, Newman BM. Repeat participation in colorectal cancer screening utilizing fecal occult blood testing: a community-based project in a rural setting. J Gastroenterol Hepatol. 2010;25(10):1661–7.CrossRefPubMed
8.
go back to reference Cole SR, Gregory TA, Whibley A, Ward PR, Turnbull D, Wilson C, et al. Predictors of re-participation in faecal occult blood test-based screening for colorectal cancer. Asian Pac J Cancer Prev. 2012;13(12):5989–94.CrossRefPubMed Cole SR, Gregory TA, Whibley A, Ward PR, Turnbull D, Wilson C, et al. Predictors of re-participation in faecal occult blood test-based screening for colorectal cancer. Asian Pac J Cancer Prev. 2012;13(12):5989–94.CrossRefPubMed
9.
go back to reference Coyle C, Kinnear H, Rosato M, Mairs A, Hall C, O’Reilly D. Do women who intermittently attend breast screening differ from those who attend every invitation and those who never attend? J Med Screen. 2014;21(2):98–103.CrossRefPubMed Coyle C, Kinnear H, Rosato M, Mairs A, Hall C, O’Reilly D. Do women who intermittently attend breast screening differ from those who attend every invitation and those who never attend? J Med Screen. 2014;21(2):98–103.CrossRefPubMed
10.
go back to reference Lo SH, Halloran S, Snowball J, Seaman H, Wardle J, von Wagner C. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme. Gut. 2014:gutjnl-2013-306144. Lo SH, Halloran S, Snowball J, Seaman H, Wardle J, von Wagner C. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme. Gut. 2014:gutjnl-2013-306144.
11.
go back to reference Duncan A, Turnbull D, Wilson C, Osborne JM, Cole SR, Flight I, et al. Behavioural and demographic predictors of adherence to three consecutive faecal occult blood test screening opportunities: a population study. BMC Public Health. 2014;14:238.CrossRefPubMedPubMedCentral Duncan A, Turnbull D, Wilson C, Osborne JM, Cole SR, Flight I, et al. Behavioural and demographic predictors of adherence to three consecutive faecal occult blood test screening opportunities: a population study. BMC Public Health. 2014;14:238.CrossRefPubMedPubMedCentral
12.
go back to reference Chapple A, Ziebland S, Hewitson P, McPherson A. What affects the uptake of screening for bowel cancer using a faecal occult blood test (FOBt): a qualitative study. Soc Sci Med. 2008;66(12):2425–35.CrossRefPubMed Chapple A, Ziebland S, Hewitson P, McPherson A. What affects the uptake of screening for bowel cancer using a faecal occult blood test (FOBt): a qualitative study. Soc Sci Med. 2008;66(12):2425–35.CrossRefPubMed
13.
go back to reference Worthley DL, Cole SR, Esterman A, Mehaffey S, Roosa N, Smith A, et al. Screening for colorectal cancer by faecal occult blood test: why people choose to refuse. Intern Med J. 2006;36(9):607–10.CrossRefPubMed Worthley DL, Cole SR, Esterman A, Mehaffey S, Roosa N, Smith A, et al. Screening for colorectal cancer by faecal occult blood test: why people choose to refuse. Intern Med J. 2006;36(9):607–10.CrossRefPubMed
14.
go back to reference Palmer C, Thomas M, Von Wagner C, Raine R. Reasons for non-uptake and subsequent participation in the NHS bowel cancer screening programme: a qualitative study. Br J Cancer. 2014;110(7):1705–11.CrossRefPubMedPubMedCentral Palmer C, Thomas M, Von Wagner C, Raine R. Reasons for non-uptake and subsequent participation in the NHS bowel cancer screening programme: a qualitative study. Br J Cancer. 2014;110(7):1705–11.CrossRefPubMedPubMedCentral
15.
go back to reference Duncan A, Turnbull D, Gregory T, Cole S, Young G, Flight I, et al. Using the Transtheoretical model of behaviour change to describe readiness to rescreen for colorectal cancer with faecal occult blood testing. Health Promot J Austr. 2012;23(2):122–8.PubMed Duncan A, Turnbull D, Gregory T, Cole S, Young G, Flight I, et al. Using the Transtheoretical model of behaviour change to describe readiness to rescreen for colorectal cancer with faecal occult blood testing. Health Promot J Austr. 2012;23(2):122–8.PubMed
16.
go back to reference Kerber RA, Neklason DW, Samowitz WS, Burt RW. Frequency of familial colon cancer and hereditary nonpolyposis colorectal cancer (lynch syndrome) in a large population database. Familial Cancer. 2005;4(3):239–44.CrossRefPubMed Kerber RA, Neklason DW, Samowitz WS, Burt RW. Frequency of familial colon cancer and hereditary nonpolyposis colorectal cancer (lynch syndrome) in a large population database. Familial Cancer. 2005;4(3):239–44.CrossRefPubMed
18.
go back to reference Australian Bureau of Statistics. Census of population and housing: socio-economic indexes far areas (SEIFA), South Australia 2033.4.30.001. http//www.abs.gov.au/austats/. Accessed 26 May 2007. Australian Bureau of Statistics. Census of population and housing: socio-economic indexes far areas (SEIFA), South Australia 2033.4.30.001. http//www.​abs.​gov.​au/​austats/​. Accessed 26 May 2007.
19.
go back to reference Murphy CC, Vernon SW, Haddock NM, Anderson ML, Chubak J, Green BB. Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial. Prev Med. 2014;66:123–30.CrossRefPubMedPubMedCentral Murphy CC, Vernon SW, Haddock NM, Anderson ML, Chubak J, Green BB. Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial. Prev Med. 2014;66:123–30.CrossRefPubMedPubMedCentral
20.
go back to reference Pornet C, Denis B, Perrin P, Gendre I, Launoy G. Predictors of adherence to repeat fecal occult blood test in a population-based colorectal cancer screening program. Br J Cancer. 2014;111(11):2152–5.CrossRefPubMedPubMedCentral Pornet C, Denis B, Perrin P, Gendre I, Launoy G. Predictors of adherence to repeat fecal occult blood test in a population-based colorectal cancer screening program. Br J Cancer. 2014;111(11):2152–5.CrossRefPubMedPubMedCentral
21.
go back to reference Lo S, Halloran S, Snowball J, Seaman H, Wardle J, Von Wagner C. Predictors of repeat participation in the NHS bowel cancer screening programme. Br J Cancer. 2015;112(1):199–206.CrossRefPubMed Lo S, Halloran S, Snowball J, Seaman H, Wardle J, Von Wagner C. Predictors of repeat participation in the NHS bowel cancer screening programme. Br J Cancer. 2015;112(1):199–206.CrossRefPubMed
22.
go back to reference Le Retraite L, Eisinger F, Loundou A, Rinaldi Y, Seitz J-F, Auquier P. Sociogeographical factors associated with participation in colorectal cancer screening. Gastroenterologie clinique et biologique. 2010;34(10):534–40.CrossRefPubMed Le Retraite L, Eisinger F, Loundou A, Rinaldi Y, Seitz J-F, Auquier P. Sociogeographical factors associated with participation in colorectal cancer screening. Gastroenterologie clinique et biologique. 2010;34(10):534–40.CrossRefPubMed
23.
go back to reference Pornet C, Dejardin O, Morlais F, Bouvier V, Launoy G. Socioeconomic determinants for compliance to colorectal cancer screening. A multilevel analysis. J Epidemiol Community Health. 2010;64(4):318–24.CrossRefPubMed Pornet C, Dejardin O, Morlais F, Bouvier V, Launoy G. Socioeconomic determinants for compliance to colorectal cancer screening. A multilevel analysis. J Epidemiol Community Health. 2010;64(4):318–24.CrossRefPubMed
24.
go back to reference Ward PR, Javanparast S, Ah Matt M, Martini A, Tsourtos G, Cole S, et al. Equity of colorectal cancer screening: cross-sectional analysis of National Bowel Cancer Screening Program data for South Australia. Aust N Z J Public Health. 2011;35(1):61–5.CrossRefPubMed Ward PR, Javanparast S, Ah Matt M, Martini A, Tsourtos G, Cole S, et al. Equity of colorectal cancer screening: cross-sectional analysis of National Bowel Cancer Screening Program data for South Australia. Aust N Z J Public Health. 2011;35(1):61–5.CrossRefPubMed
25.
go back to reference Australian Institute of Health and Welfare. National Bowel Cancer Screening Program: monitoring report 2017. CAN 103 ed. Canberra: AIHW; 2017. Australian Institute of Health and Welfare. National Bowel Cancer Screening Program: monitoring report 2017. CAN 103 ed. Canberra: AIHW; 2017.
26.
go back to reference Honein-AbouHaidar GN, Kastner M, Vuong V, Perrier L, Daly C, Rabeneck L, et al. Systematic review and meta-study synthesis of qualitative studies evaluating facilitators and barriers to participation in colorectal cancer screening. Cancer Epidemiology Biomarkers & Prevention. 2016:cebp. 0990.2015. Honein-AbouHaidar GN, Kastner M, Vuong V, Perrier L, Daly C, Rabeneck L, et al. Systematic review and meta-study synthesis of qualitative studies evaluating facilitators and barriers to participation in colorectal cancer screening. Cancer Epidemiology Biomarkers & Prevention. 2016:cebp. 0990.2015.
27.
go back to reference Oster C, Zajac I, Flight I, Hart E, Young GP, Wilson C, et al. Ambivalence and its influence on participation in screening for colorectal cancer. Qual Health Res. 2013;23(9):1188–201.CrossRefPubMed Oster C, Zajac I, Flight I, Hart E, Young GP, Wilson C, et al. Ambivalence and its influence on participation in screening for colorectal cancer. Qual Health Res. 2013;23(9):1188–201.CrossRefPubMed
28.
go back to reference Peipins LA, Shapiro JA, Bobo JK, Berkowitz Z. Impact of women’s experiences during mammography on adherence to rescreening (United States). Cancer Causes Control. 2006;17(4):439–47.CrossRefPubMed Peipins LA, Shapiro JA, Bobo JK, Berkowitz Z. Impact of women’s experiences during mammography on adherence to rescreening (United States). Cancer Causes Control. 2006;17(4):439–47.CrossRefPubMed
29.
go back to reference Goossens M, Van Hal G, Van der Burg M, Kellen E, Van Herck K, De Grève J, et al. Quantifying independent risk factors for failing to rescreen in a breast cancer screening program in Flanders, Belgium. Prev Med. 2014;69:280–6.CrossRefPubMed Goossens M, Van Hal G, Van der Burg M, Kellen E, Van Herck K, De Grève J, et al. Quantifying independent risk factors for failing to rescreen in a breast cancer screening program in Flanders, Belgium. Prev Med. 2014;69:280–6.CrossRefPubMed
30.
go back to reference Ouellette JA, Wood W. Habit and intention in everyday life: the multiple processes by which past behavior predicts future behavior. Psychol Bull. 1998;124(1):54.CrossRef Ouellette JA, Wood W. Habit and intention in everyday life: the multiple processes by which past behavior predicts future behavior. Psychol Bull. 1998;124(1):54.CrossRef
31.
go back to reference Osborne JM, Wilson C, Moore V, Gregory T, Flight I, Young GP. Sample preference for colorectal cancer screening tests: blood or stool? Open J Prev Med. 2012;2(3):326–31.CrossRef Osborne JM, Wilson C, Moore V, Gregory T, Flight I, Young GP. Sample preference for colorectal cancer screening tests: blood or stool? Open J Prev Med. 2012;2(3):326–31.CrossRef
32.
go back to reference Cole S, Young G, Byrne D, Guy J, Morcom J. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. J Med Screen. 2002;9(4):147–52.CrossRefPubMed Cole S, Young G, Byrne D, Guy J, Morcom J. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. J Med Screen. 2002;9(4):147–52.CrossRefPubMed
Metadata
Title
Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?
Authors
Joanne M. Osborne
Carlene Wilson
Amy Duncan
Stephen R. Cole
Ingrid Flight
Deborah Turnbull
Donna L. Hughes
Graeme P. Young
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2018
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-017-4634-8

Other articles of this Issue 1/2018

BMC Public Health 1/2018 Go to the issue